Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-04-004076
Filing Date
2004-02-11
Accepted
2004-02-11 17:25:49
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2128606z10-ka.txt 10-K/A 100661
3 EXHIBIT 23.1 a2128606zex-23_1.txt EX-23.1 698
4 EXHIBIT 31.1 a2128606zex-31_1.txt EX-31.1 3676
5 EXHIBIT 31.2 a2128606zex-31_2.txt EX-31.2 3690
6 EXHIBIT 32.1 a2128606zex-32_1.txt EX-32.1 1509
7 EXHIBIT 32.2 a2128606zex-32_2.txt EX-32.2 1525
  Complete submission text file 0001047469-04-004076.txt   113862
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30981 | Film No.: 04587417
SIC: 8731 Services-Commercial Physical & Biological Research